- GROUP Adolescent & Young Adult
- PROJECT SPAN 2015
- DATE 01/05/2015
AYA Research Agenda Workshop
This workshop was held by the COSA AYA Executive Committee to examine and develop a strategic plan of action to address four specific areas affecting AYA research in Australia.
Details on this project
The COSA AYA Executive Committee held an initial workshop in March 2014 to develop a national AYA research strategy. Representation at this workshop included COSA, Cancer Australia, Canteen, Australian Association of Adolescent Health, and eight of the Cancer Cooperative Trials Groups (CCTGs).
A second AYA research strategy workshop was held in May 2015 to address four specific areas of focus derived from discussions held during the initial workshop brainstorming session which centred around nontherapy issues affecting AYA research. The four main areas addressed were:
- Lowering the age of eligibility
- Collaborative opportunities for AYA clinical trial development and access
- A virtual national tumour bank
- A national clinical trials app
The overall purpose of the workshop was to provide an opportunity to examine these four areas in depth and develop a strategic plan of action to address the issues in these areas which form significant barriers to AYA research in Australia.
Related projects
Adolescent & Young Adult
Guidelines for the Psychosocial Management of AYAs Diagnosed with Cancer
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 4 hours ago
Our Cancer Pharmacists Group Clinical Development Workshop is back! This 3-hour educational afternoon will take place on Tuesday 11 November at the Adelaide Convention Centre. COSA CPG members and other interested pharmacists are encouraged to attend.
Read More >
COSAoncology yesterday
Save the date for the PGX Debate! COSA, @CAPhO_ACPhO @ISOPPorg and @BOPACommittee leaders will face off in a lively 3-minute-thesis-style debate - Is pharmacogenomics over-rated? - Evidence, energy and humour guaranteed! Tuesday 28 October 8:00PM AEDT
Read More >
COSAoncology 7 days ago
It is just six weeks till the multidisciplinary cancer care community meets in Adelaide for #COSAIPOS2025 to share insights, highlight innovation and influence best practice. View the packed program
Read More >
COSAoncology 15 days ago
Catch the Highlights of ISOPP CAPhO Symposium 2025 in a live webinar Saturday 27 September 7:30am AEST. Speakers include @DrKEWatson, Melanie Danilak & Prof Lita Chew. The webinar is free for members of @COSAoncology @ISOPPorg @CAPhO_ACPhO @BOPACommittee.
Read More >
COSAoncology 15 days ago
Our September member newsletter is out now. Check your inbox for COSA news – opportunities, group and affiliate updates, webinars, journal articles and more. Or log in and read it online anytime at
Read More >
COSAoncology 16 days ago
Check your inbox for the September Nutrition Group eNews for journal articles, PD, resources and more. If you're not subscribed, login to your COSA member account
Read More >
COSAoncology 22 days ago
@COSAoncology @ASCO @EuropeanCancer are using their collective voices to raise awareness of challenges impacting the wellbeing of health professionals and to define principles for creating healthy workplace cultures in health systems. See Lancet Oncology
Read More >
COSAoncology 22 days ago
Exercise & Cancer / Global Oncology Group Fellowship opportunities! COSA is offering two Fellowships to early-mid career researchers to coordinate and lead a study to develop a model of care for exercise oncology for a lower-middle-income country setting.
Read More >
COSAoncology 23 days ago
The latest Survivorship eNews is out now! With working group updates, new COSA-endorsed resources, journal articles, COSA-IPOS 2025 key survivorship sessions & more. Check your inbox, visit
Read More >
COSAoncology 23 days ago
Cancer Pharmacists Group Fellowship opportunity! COSA is offering an early career researcher mentorship, guidance and support to develop a COSA position statement on 'Documentation of Hypersensitivity Reactions to SACT'. Find out more
Read More >